0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-Opioid Pain Treatment Market Size, Status and Forecast 2021-2027
Published Date: July 2021
|
Report Code: QYRE-Auto-37U5878
Home | Market Reports | Health | Health Conditions | Pain Management
Global Non Opioid Pain Treatment Market Size Status and Forecast 2021 2027

Global Non-Opioid Pain Treatment Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-37U5878
Report
July 2021
106 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Non-Opioid Pain Treatment address acute and chronic pain and regulatory issues faced by healthcare professionals.
With growing concerns about the addictive nature of opioid painkillers, more and more companies are working to develop effective but not addictive therapies. The interest and demand for Non-Opioid has increased significantly.
Market Analysis and Insights: Global Non-Opioid Pain Treatment Market
The global Non-Opioid Pain Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Non-Opioid Pain Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Non-Opioid Pain Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Non-Opioid Pain Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Non-Opioid Pain Treatment market.
Global Non-Opioid Pain Treatment Scope and Market Size
Non-Opioid Pain Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-Opioid Pain Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

Medical Cannabis Treatment
Capsaicin-derived Treatment
Menthol-containing Treatment
Omega 3 fatty acid-containing Treatment
Botulinum Toxins

Segment by Application

Orthopaedic and Musculoskeletal Pain
Neuropathic Pain
Cancer Pain
Others

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

Allergan PLC
Canopy Growth
Medical Marijuana Inc.
Panag Pharma Inc.
Tilray
Aphria Inc.
Bedrocan
Cara Therapeutics
Centrexion Therapeutics
CHT Medical
Cronos Group
GW Pharmaceuticals
Medropharm Gmbh
US Worldmeds LLC
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Opioid Pain Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medical Cannabis Treatment
1.2.3 Capsaicin-derived Treatment
1.2.4 Menthol-containing Treatment
1.2.5 Omega 3 fatty acid-containing Treatment
1.2.6 Botulinum Toxins
1.3 Market by Application
1.3.1 Global Non-Opioid Pain Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Orthopaedic and Musculoskeletal Pain
1.3.3 Neuropathic Pain
1.3.4 Cancer Pain
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Non-Opioid Pain Treatment Market Perspective (2016-2027)
2.2 Non-Opioid Pain Treatment Growth Trends by Regions
2.2.1 Non-Opioid Pain Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Non-Opioid Pain Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Non-Opioid Pain Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Non-Opioid Pain Treatment Industry Dynamic
2.3.1 Non-Opioid Pain Treatment Market Trends
2.3.2 Non-Opioid Pain Treatment Market Drivers
2.3.3 Non-Opioid Pain Treatment Market Challenges
2.3.4 Non-Opioid Pain Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Opioid Pain Treatment Players by Revenue
3.1.1 Global Top Non-Opioid Pain Treatment Players by Revenue (2016-2021)
3.1.2 Global Non-Opioid Pain Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Non-Opioid Pain Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Non-Opioid Pain Treatment Revenue
3.4 Global Non-Opioid Pain Treatment Market Concentration Ratio
3.4.1 Global Non-Opioid Pain Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Opioid Pain Treatment Revenue in 2020
3.5 Non-Opioid Pain Treatment Key Players Head office and Area Served
3.6 Key Players Non-Opioid Pain Treatment Product Solution and Service
3.7 Date of Enter into Non-Opioid Pain Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Opioid Pain Treatment Breakdown Data by Type
4.1 Global Non-Opioid Pain Treatment Historic Market Size by Type (2016-2021)
4.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Type (2022-2027)
5 Non-Opioid Pain Treatment Breakdown Data by Application
5.1 Global Non-Opioid Pain Treatment Historic Market Size by Application (2016-2021)
5.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Non-Opioid Pain Treatment Market Size (2016-2027)
6.2 North America Non-Opioid Pain Treatment Market Size by Type
6.2.1 North America Non-Opioid Pain Treatment Market Size by Type (2016-2021)
6.2.2 North America Non-Opioid Pain Treatment Market Size by Type (2022-2027)
6.2.3 North America Non-Opioid Pain Treatment Market Size by Type (2016-2027)
6.3 North America Non-Opioid Pain Treatment Market Size by Application
6.3.1 North America Non-Opioid Pain Treatment Market Size by Application (2016-2021)
6.3.2 North America Non-Opioid Pain Treatment Market Size by Application (2022-2027)
6.3.3 North America Non-Opioid Pain Treatment Market Size by Application (2016-2027)
6.4 North America Non-Opioid Pain Treatment Market Size by Country
6.4.1 North America Non-Opioid Pain Treatment Market Size by Country (2016-2021)
6.4.2 North America Non-Opioid Pain Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Non-Opioid Pain Treatment Market Size (2016-2027)
7.2 Europe Non-Opioid Pain Treatment Market Size by Type
7.2.1 Europe Non-Opioid Pain Treatment Market Size by Type (2016-2021)
7.2.2 Europe Non-Opioid Pain Treatment Market Size by Type (2022-2027)
7.2.3 Europe Non-Opioid Pain Treatment Market Size by Type (2016-2027)
7.3 Europe Non-Opioid Pain Treatment Market Size by Application
7.3.1 Europe Non-Opioid Pain Treatment Market Size by Application (2016-2021)
7.3.2 Europe Non-Opioid Pain Treatment Market Size by Application (2022-2027)
7.3.3 Europe Non-Opioid Pain Treatment Market Size by Application (2016-2027)
7.4 Europe Non-Opioid Pain Treatment Market Size by Country
7.4.1 Europe Non-Opioid Pain Treatment Market Size by Country (2016-2021)
7.4.2 Europe Non-Opioid Pain Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Non-Opioid Pain Treatment Market Size (2016-2027)
8.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type
8.2.1 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application
8.3.1 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region
8.4.1 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Non-Opioid Pain Treatment Market Size (2016-2027)
9.2 Latin America Non-Opioid Pain Treatment Market Size by Type
9.2.1 Latin America Non-Opioid Pain Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Non-Opioid Pain Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Non-Opioid Pain Treatment Market Size by Type (2016-2027)
9.3 Latin America Non-Opioid Pain Treatment Market Size by Application
9.3.1 Latin America Non-Opioid Pain Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Non-Opioid Pain Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Non-Opioid Pain Treatment Market Size by Application (2016-2027)
9.4 Latin America Non-Opioid Pain Treatment Market Size by Country
9.4.1 Latin America Non-Opioid Pain Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Non-Opioid Pain Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Opioid Pain Treatment Market Size (2016-2027)
10.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type
10.2.1 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application
10.3.1 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country
10.4.1 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan PLC
11.1.1 Allergan PLC Company Details
11.1.2 Allergan PLC Business Overview
11.1.3 Allergan PLC Non-Opioid Pain Treatment Introduction
11.1.4 Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.1.5 Allergan PLC Recent Development
11.2 Canopy Growth
11.2.1 Canopy Growth Company Details
11.2.2 Canopy Growth Business Overview
11.2.3 Canopy Growth Non-Opioid Pain Treatment Introduction
11.2.4 Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.2.5 Canopy Growth Recent Development
11.3 Medical Marijuana Inc.
11.3.1 Medical Marijuana Inc. Company Details
11.3.2 Medical Marijuana Inc. Business Overview
11.3.3 Medical Marijuana Inc. Non-Opioid Pain Treatment Introduction
11.3.4 Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.3.5 Medical Marijuana Inc. Recent Development
11.4 Panag Pharma Inc.
11.4.1 Panag Pharma Inc. Company Details
11.4.2 Panag Pharma Inc. Business Overview
11.4.3 Panag Pharma Inc. Non-Opioid Pain Treatment Introduction
11.4.4 Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.4.5 Panag Pharma Inc. Recent Development
11.5 Tilray
11.5.1 Tilray Company Details
11.5.2 Tilray Business Overview
11.5.3 Tilray Non-Opioid Pain Treatment Introduction
11.5.4 Tilray Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.5.5 Tilray Recent Development
11.6 Aphria Inc.
11.6.1 Aphria Inc. Company Details
11.6.2 Aphria Inc. Business Overview
11.6.3 Aphria Inc. Non-Opioid Pain Treatment Introduction
11.6.4 Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.6.5 Aphria Inc. Recent Development
11.7 Bedrocan
11.7.1 Bedrocan Company Details
11.7.2 Bedrocan Business Overview
11.7.3 Bedrocan Non-Opioid Pain Treatment Introduction
11.7.4 Bedrocan Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.7.5 Bedrocan Recent Development
11.8 Cara Therapeutics
11.8.1 Cara Therapeutics Company Details
11.8.2 Cara Therapeutics Business Overview
11.8.3 Cara Therapeutics Non-Opioid Pain Treatment Introduction
11.8.4 Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.8.5 Cara Therapeutics Recent Development
11.9 Centrexion Therapeutics
11.9.1 Centrexion Therapeutics Company Details
11.9.2 Centrexion Therapeutics Business Overview
11.9.3 Centrexion Therapeutics Non-Opioid Pain Treatment Introduction
11.9.4 Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.9.5 Centrexion Therapeutics Recent Development
11.10 CHT Medical
11.10.1 CHT Medical Company Details
11.10.2 CHT Medical Business Overview
11.10.3 CHT Medical Non-Opioid Pain Treatment Introduction
11.10.4 CHT Medical Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.10.5 CHT Medical Recent Development
11.11 Cronos Group
11.11.1 Cronos Group Company Details
11.11.2 Cronos Group Business Overview
11.11.3 Cronos Group Non-Opioid Pain Treatment Introduction
11.11.4 Cronos Group Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.11.5 Cronos Group Recent Development
11.12 GW Pharmaceuticals
11.12.1 GW Pharmaceuticals Company Details
11.12.2 GW Pharmaceuticals Business Overview
11.12.3 GW Pharmaceuticals Non-Opioid Pain Treatment Introduction
11.12.4 GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.12.5 GW Pharmaceuticals Recent Development
11.13 Medropharm Gmbh
11.13.1 Medropharm Gmbh Company Details
11.13.2 Medropharm Gmbh Business Overview
11.13.3 Medropharm Gmbh Non-Opioid Pain Treatment Introduction
11.13.4 Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.13.5 Medropharm Gmbh Recent Development
11.14 US Worldmeds LLC
11.14.1 US Worldmeds LLC Company Details
11.14.2 US Worldmeds LLC Business Overview
11.14.3 US Worldmeds LLC Non-Opioid Pain Treatment Introduction
11.14.4 US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.14.5 US Worldmeds LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Non-Opioid Pain Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Medical Cannabis Treatment
    Table 3. Key Players of Capsaicin-derived Treatment
    Table 4. Key Players of Menthol-containing Treatment
    Table 5. Key Players of Omega 3 fatty acid-containing Treatment
    Table 6. Key Players of Botulinum Toxins
    Table 7. Global Non-Opioid Pain Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Non-Opioid Pain Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Non-Opioid Pain Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Non-Opioid Pain Treatment Market Share by Regions (2016-2021)
    Table 11. Global Non-Opioid Pain Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Non-Opioid Pain Treatment Market Share by Regions (2022-2027)
    Table 13. Non-Opioid Pain Treatment Market Trends
    Table 14. Non-Opioid Pain Treatment Market Drivers
    Table 15. Non-Opioid Pain Treatment Market Challenges
    Table 16. Non-Opioid Pain Treatment Market Restraints
    Table 17. Global Non-Opioid Pain Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Non-Opioid Pain Treatment Market Share by Players (2016-2021)
    Table 19. Global Top Non-Opioid Pain Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Opioid Pain Treatment as of 2020)
    Table 20. Ranking of Global Top Non-Opioid Pain Treatment Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Non-Opioid Pain Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Non-Opioid Pain Treatment Product Solution and Service
    Table 24. Date of Enter into Non-Opioid Pain Treatment Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Non-Opioid Pain Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2016-2021)
    Table 28. Global Non-Opioid Pain Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Non-Opioid Pain Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Non-Opioid Pain Treatment Revenue Market Share by Application (2016-2021)
    Table 32. Global Non-Opioid Pain Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Non-Opioid Pain Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Non-Opioid Pain Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Non-Opioid Pain Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Non-Opioid Pain Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Non-Opioid Pain Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Non-Opioid Pain Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 39. North America Non-Opioid Pain Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 40. Europe Non-Opioid Pain Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Non-Opioid Pain Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Non-Opioid Pain Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Non-Opioid Pain Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Non-Opioid Pain Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 45. Europe Non-Opioid Pain Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2016-2021) & (US$ Million)
    Table 51. Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2022-2027) & (US$ Million)
    Table 52. Latin America Non-Opioid Pain Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Non-Opioid Pain Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Non-Opioid Pain Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Non-Opioid Pain Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Non-Opioid Pain Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 57. Latin America Non-Opioid Pain Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 63. Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 64. Allergan PLC Company Details
    Table 65. Allergan PLC Business Overview
    Table 66. Allergan PLC Non-Opioid Pain Treatment Product
    Table 67. Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
    Table 68. Allergan PLC Recent Development
    Table 69. Canopy Growth Company Details
    Table 70. Canopy Growth Business Overview
    Table 71. Canopy Growth Non-Opioid Pain Treatment Product
    Table 72. Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
    Table 73. Canopy Growth Recent Development
    Table 74. Medical Marijuana Inc. Company Details
    Table 75. Medical Marijuana Inc. Business Overview
    Table 76. Medical Marijuana Inc. Non-Opioid Pain Treatment Product
    Table 77. Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
    Table 78. Medical Marijuana Inc. Recent Development
    Table 79. Panag Pharma Inc. Company Details
    Table 80. Panag Pharma Inc. Business Overview
    Table 81. Panag Pharma Inc. Non-Opioid Pain Treatment Product
    Table 82. Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
    Table 83. Panag Pharma Inc. Recent Development
    Table 84. Tilray Company Details
    Table 85. Tilray Business Overview
    Table 86. Tilray Non-Opioid Pain Treatment Product
    Table 87. Tilray Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
    Table 88. Tilray Recent Development
    Table 89. Aphria Inc. Company Details
    Table 90. Aphria Inc. Business Overview
    Table 91. Aphria Inc. Non-Opioid Pain Treatment Product
    Table 92. Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
    Table 93. Aphria Inc. Recent Development
    Table 94. Bedrocan Company Details
    Table 95. Bedrocan Business Overview
    Table 96. Bedrocan Non-Opioid Pain Treatment Product
    Table 97. Bedrocan Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
    Table 98. Bedrocan Recent Development
    Table 99. Cara Therapeutics Company Details
    Table 100. Cara Therapeutics Business Overview
    Table 101. Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
    Table 102. Cara Therapeutics Recent Development
    Table 103. Centrexion Therapeutics Company Details
    Table 104. Centrexion Therapeutics Business Overview
    Table 105. Centrexion Therapeutics Non-Opioid Pain Treatment Product
    Table 106. Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
    Table 107. Centrexion Therapeutics Recent Development
    Table 108. CHT Medical Company Details
    Table 109. CHT Medical Business Overview
    Table 110. CHT Medical Non-Opioid Pain Treatment Product
    Table 111. CHT Medical Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
    Table 112. CHT Medical Recent Development
    Table 113. Cronos Group Company Details
    Table 114. Cronos Group Business Overview
    Table 115. Cronos Group Non-Opioid Pain Treatment Product
    Table 116. Cronos Group Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
    Table 117. Cronos Group Recent Development
    Table 118. GW Pharmaceuticals Company Details
    Table 119. GW Pharmaceuticals Business Overview
    Table 120. GW Pharmaceuticals Non-Opioid Pain Treatment Product
    Table 121. GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
    Table 122. GW Pharmaceuticals Recent Development
    Table 123. Medropharm Gmbh Company Details
    Table 124. Medropharm Gmbh Business Overview
    Table 125. Medropharm Gmbh Non-Opioid Pain Treatment Product
    Table 126. Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
    Table 127. Medropharm Gmbh Recent Development
    Table 128. US Worldmeds LLC Company Details
    Table 129. US Worldmeds LLC Business Overview
    Table 130. US Worldmeds LLC Non-Opioid Pain Treatment Product
    Table 131. US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
    Table 132. US Worldmeds LLC Recent Development
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Non-Opioid Pain Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Medical Cannabis Treatment Features
    Figure 3. Capsaicin-derived Treatment Features
    Figure 4. Menthol-containing Treatment Features
    Figure 5. Omega 3 fatty acid-containing Treatment Features
    Figure 6. Botulinum Toxins Features
    Figure 7. Global Non-Opioid Pain Treatment Market Share by Application: 2020 VS 2027
    Figure 8. Orthopaedic and Musculoskeletal Pain Case Studies
    Figure 9. Neuropathic Pain Case Studies
    Figure 10. Cancer Pain Case Studies
    Figure 11. Others Case Studies
    Figure 12. Non-Opioid Pain Treatment Report Years Considered
    Figure 13. Global Non-Opioid Pain Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 14. Global Non-Opioid Pain Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global Non-Opioid Pain Treatment Market Share by Regions: 2020 VS 2027
    Figure 16. Global Non-Opioid Pain Treatment Market Share by Regions (2022-2027)
    Figure 17. Global Non-Opioid Pain Treatment Market Share by Players in 2020
    Figure 18. Global Top Non-Opioid Pain Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Opioid Pain Treatment as of 2020
    Figure 19. The Top 10 and 5 Players Market Share by Non-Opioid Pain Treatment Revenue in 2020
    Figure 20. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2016-2021)
    Figure 21. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2022-2027)
    Figure 22. North America Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. North America Non-Opioid Pain Treatment Market Share by Type (2016-2027)
    Figure 24. North America Non-Opioid Pain Treatment Market Share by Application (2016-2027)
    Figure 25. North America Non-Opioid Pain Treatment Market Share by Country (2016-2027)
    Figure 26. United States Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Canada Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Non-Opioid Pain Treatment Market Share by Type (2016-2027)
    Figure 30. Europe Non-Opioid Pain Treatment Market Share by Application (2016-2027)
    Figure 31. Europe Non-Opioid Pain Treatment Market Share by Country (2016-2027)
    Figure 32. Germany Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. France Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. U.K. Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Italy Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Russia Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Nordic Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Non-Opioid Pain Treatment Market Share by Type (2016-2027)
    Figure 40. Asia-Pacific Non-Opioid Pain Treatment Market Share by Application (2016-2027)
    Figure 41. Asia-Pacific Non-Opioid Pain Treatment Market Share by Region (2016-2027)
    Figure 42. China Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Japan Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. South Korea Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Southeast Asia Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. India Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Australia Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Non-Opioid Pain Treatment Market Share by Type (2016-2027)
    Figure 50. Latin America Non-Opioid Pain Treatment Market Share by Application (2016-2027)
    Figure 51. Latin America Non-Opioid Pain Treatment Market Share by Country (2016-2027)
    Figure 52. Mexico Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Brazil Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Non-Opioid Pain Treatment Market Share by Type (2016-2027)
    Figure 56. Middle East & Africa Non-Opioid Pain Treatment Market Share by Application (2016-2027)
    Figure 57. Middle East & Africa Non-Opioid Pain Treatment Market Share by Country (2016-2027)
    Figure 58. Turkey Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Saudi Arabia Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. UAE Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Allergan PLC Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
    Figure 62. Canopy Growth Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
    Figure 63. Medical Marijuana Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
    Figure 64. Panag Pharma Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
    Figure 65. Tilray Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
    Figure 66. Aphria Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
    Figure 67. Bedrocan Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
    Figure 68. Cara Therapeutics Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
    Figure 69. Centrexion Therapeutics Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
    Figure 70. CHT Medical Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
    Figure 71. Cronos Group Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
    Figure 72. GW Pharmaceuticals Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
    Figure 73. Medropharm Gmbh Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
    Figure 74. US Worldmeds LLC Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Samsung SD

RELATED REPORTS

Global and United States Knee Pain Management Market Size Status and Forecast 2021 2027
Global and United States Knee Pain Management Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-30J6482
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global Ibuprofen API Sales Market Report 2021
Global Ibuprofen API Sales Market Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-12X6333
Wed Aug 11 00:00:00 UTC 2021

Add to Cart

China Acute Migraine Drugs Market Report Forecast 2021 2027
China Acute Migraine Drugs Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-15T1655
Wed Aug 11 00:00:00 UTC 2021

Add to Cart

China Acetaminophen Market Report Forecast 2021 2027
China Acetaminophen Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-1579
Wed Aug 11 00:00:00 UTC 2021

Add to Cart